企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
SK Bioscience Co.,Ltd was established on July 1, 2018 through a spin-off, based on the capabilities accumulated as the vaccine business division within SK Chemicals. Under its mission to promote human health from prevention to treatment, the company has built its own vaccine portfolio and continuously pursued global projects, accelerating its performance. In particular, through a two-track strategy of global vaccine C(D)MO and in-house vaccine development, the company successfully responded to the COVID-19 pandemic, building a high level of capability and network in the vaccine field.
代表理事
Ahn Jaeyong
成立日期
2018年7月1日
法人类型
韩国综合股价指数
行业分类
Manufacture of medicinal chemicals
法人注册号
13111-0523736
营业执照号
818-86-00991
电话号码
032-209-5000
传真号码
02-2008-2739
公司地址
38 Yeongudanji-ro, Yeonsu-gu, Incheon
产品与服务
评论